Lifecore Biomedical, Inc.
LFCR· Nasdaq
LFCRLifecore Biomedical, Inc.
Filed Jan 4, 2013 · 10-Q · 40 days after period end · 0001437749-13-000212
| Metric | Q2 2013 | Q2 2012 | Q2 2011 |
|---|---|---|---|
| Revenue | $114.65M | $81.57M | $70.17M |
| Net Income | $8.91M | $3.34M | $2.06M |
| EPS Diluted | $0.34 | $0.13 | $0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Lifecore Biomedical, Inc. · CIK 1005286 · Engraved from SEC EDGAR
ended Nov 25, 2012 · filed Jan 4, 2013 · 40 d after period end
